EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

Indian Pharma’s 2026 Pivot: $19B US Expansion, M&A Deals, and Specialty Drug Revolution - Indian pharmaceutical companies are executing a strategic pivot in 2026 — doubling down on specialty drugs and biosimilars through record-breaking M&A and US investment, while maintaining their core generics business as the foundation of global supply. The dual-track strategy comes as a $142 billion-plus patent cliff opens opportunities and US generics tariff exemptions protect the […]
India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16% - The Indian pharmaceutical sector enters the second half of 2026 with significant momentum as three major developments converge: the India-UK Comprehensive Economic Trade Agreement (CETA) taking effect on July 15, India extending its lead over China in US FDA drug master filings, and the domestic pharma market recording robust 16% growth in June 2026. These […]
Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026 - India’s pharmaceutical sector has entered the second half of 2026 on a strong footing, with exports rising 6.6% year-on-year and the Nifty Pharma index hitting an all-time high in early July. Despite global headwinds including geopolitical tensions in West Asia and shifting US trade policies, Indian pharma companies continue to demonstrate resilience and growth momentum, […]
India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise - India’s pharmaceutical sector continues to strengthen its global position with a series of positive developments in mid-2026. From extending its lead over China in US FDA drug master filings to falling API prices that boost manufacturer margins, and an accelerating push into biosimilars, Indian pharma is navigating a dynamic landscape with strategic confidence. This roundup […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us